ADiTx Therapeutics, Inc. Common Stock
ADiTx Therapeutics, Inc. Common Stock (ADTX) on the NASDAQ Exchange
Company overview
ADiTx Therapeutics, Inc. Common Stock is a publicly listed company from USA with shares traded on NASDAQ under the ticker ADTX. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for ADTX are bid 2.21 USD and ask 2.32 USD.
Use the chart to review recent momentum, identify key price areas, and track how ADiTx Therapeutics, Inc. Common Stock is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add ADTX to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.
Key facts
- Exchange: NASDAQ
- Company: ADiTx Therapeutics, Inc. Common Stock
- Ticker: ADTX
- Country: USA
- Bid: 2.21 USD
- Ask: 2.32 USD
- Quotes: real-time, auto-updated
Risk
Risk Warning: Past performance of ADTX does not predict future returns.
FAQ
Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for ADiTx Therapeutics, Inc. Common Stock (ADTX) in R StocksTrader. Create and verify your profile, fund the account, search for ADTX, and choose the instrument type available to you. Add ADTX to your Watchlist to track moves and manage open positions throughout 2025.
ADTX trades on NASDAQ and is issued by ADiTx Therapeutics, Inc. Common Stock. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for ADTX match your plan.
Quotes update automatically in real time. Current levels for ADTX are bid 2.21 USD and ask 2.32 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track ADTX in R StocksTrader and adjust your approach as market conditions change in 2025.